000			01596 a2200481 4500
005			20250512102950.0
264		0	_c19740222
008			197402s 0 0 eng d
022			_a0077-3670
040			_aNLM _beng _cNLM
100	1		_aTalley, R W
245	0	0	_aProceedings: Chemotherapy of soft-tissue sarcomas. _h[electronic resource]
260			_bProceedings. National Cancer Conference _c1972
300			_a89-900 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAmides _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDactinomycin _xtherapeutic use
650	0	4	_aDaunorubicin _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEvaluation Studies as Topic
650	0	4	_aFemale
650	0	4	_aFibrosarcoma _xdrug therapy
650	0	4	_aHemangiosarcoma _xdrug therapy
650	0	4	_aHistiocytoma, Benign Fibrous _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xtherapeutic use
650	0	4	_aLeiomyosarcoma _xdrug therapy
650	0	4	_aLiposarcoma _xdrug therapy
650	0	4	_aMale
650	0	4	_aMesothelioma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aRhabdomyosarcoma _xdrug therapy
650	0	4	_aSarcoma _xdrug therapy
650	0	4	_aSarcoma, Synovial _xdrug therapy
650	0	4	_aTriazenes _xtherapeutic use
773	0		_tProceedings. National Cancer Conference _gvol. 7 _gp. 89-900
999			_c4362871 _d4362871